Fiche du document
31 mars 2022
- doi: 10.1183/16000617.0112-2021
- issn: 0905-9180
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1183/16000617.0112-2021
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/35321933
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/1600-0617
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_2BEA01C77CB11
info:eu-repo/semantics/openAccess , CC BY-NC 4.0 , https://creativecommons.org/licenses/by-nc/4.0/
Sujets proches
Bronchial asthmaCiter ce document
M. Aghapour et al., « Role of air pollutants in airway epithelial barrier dysfunction in asthma and COPD. », Serveur académique Lausannois, ID : 10.1183/16000617.0112-2021
Métriques
Partage / Export
Résumé
Chronic exposure to environmental pollutants is a major contributor to the development and progression of obstructive airway diseases, including asthma and COPD. Understanding the mechanisms underlying the development of obstructive lung diseases upon exposure to inhaled pollutants will lead to novel insights into the pathogenesis, prevention and treatment of these diseases. The respiratory epithelial lining forms a robust physicochemical barrier protecting the body from inhaled toxic particles and pathogens. Inhalation of airborne particles and gases may impair airway epithelial barrier function and subsequently lead to exaggerated inflammatory responses and airway remodelling, which are key features of asthma and COPD. In addition, air pollutant-induced airway epithelial barrier dysfunction may increase susceptibility to respiratory infections, thereby increasing the risk of exacerbations and thus triggering further inflammation. In this review, we discuss the molecular and immunological mechanisms involved in physical barrier disruption induced by major airborne pollutants and outline their implications in the pathogenesis of asthma and COPD. We further discuss the link between these pollutants and changes in the lung microbiome as a potential factor for aggravating airway diseases. Understanding these mechanisms may lead to identification of novel targets for therapeutic intervention to restore airway epithelial integrity in asthma and COPD.